 |
|
About IFPF 2024
The 9th IP Forefront Pharma Forum 2024, held by YIP Events& IP Forefront New Media, will be held in Suzhou on October 16th-18th and has now begun to accept registration for cooperation. As one of the most influential and large-scale biomedical offline conferences in China, the IP Forefront Pharma Forum has been successfully held for eight consecutive terms, which has cumulatively attracted around 4,000 professionals from China and abroad to participate in the exchange and jointly witness the evolution and development in biomedical IP fieldof China. Adhering to the concept of innovation and excellence, we have always introduced cutting-edge industrial topics and diversified forms of exchange, committed to providing participants with rich opportunities for learning, exchange and cooperation, and building a high-quality platform for information sharing and business talks for the majority of biomedical IP practitioners.
Based on the profound experience of the past eight years, this forum has specially planned eight pre-conference workshops with its own characteristics. The three-day conferences will deeply analyze the key topics of biomedical frontier development trend, policy orientation, IP portfolio of hot arena technology innovation, and pharmaceutical company going overseas, comprehensively cover the new rules for patent reviews, strategic formulation of enterprise patents, patent portfolio in emerging markets, prevention and control of IP risks in going overseas and other whole industrial chain items, and help pharmaceutical company policy-makers grasp the new trends and new opportunities in market competition. At the same time, we will hold a welcoming party on the evening of October 17th to hold the Second Pharmaceutical Intelligence Star Celebration: Top IP Talents and Excellent IP TeamAward Ceremony to recognize individuals and teams who have made outstanding contributions in the field of biomedical IP rights.
The three-day conferences will continue to present wonderful topics, in-depth discussion and substantive sharing. It is expected that more than 600 professionals will gather together, and more participants from China and abroad will participate in sharing and booth exchange.
|
|
 |
|
IFPF 2024 Will Help You Understand
• In the background of the development of new quality productive forces, is the regulatory data protection system a significant link of the pharmaceutical innovative development?
• Has the early resolution mechanism for drug patent disputes achieved its original legislative purpose since its enforcement?
• As for the PTA in mist, how will enterprises and authorities feel their way across the river?
• In the domestic market full of extreme rat race, where will pharmaceutical companies go in rat race? IPer will follow wherever they go
• The chaos of generic name registration of pharmaceutical enterprises and the problems on the trademark application and layout of pharmaceutical enterprises
• The problems on the determination of patent risk prevention and infringement under the hot ADC drug racetrack
• What impact will the European Unified Patent System and Unified SPC bring about, how will enterprises deal with it?
• Comparison and analysis of the differences in patent examinationstandards between China, the United States and Europe (creativity, novelty and inadequate disclosure)
• One after another, the characteristics and layout of patents in the new racetrack of "RDC"
• Can the amendments to the draft “Regulations on the Protection of Traditional Chinese Medicine Knowledge” promote the development of Traditional Chinese Medicine?
• The new battlefields for generic and innovative drugs (Brazil, India, MENA regions, Thailand, Malaysia, Singapore and Indonesia)
• How to become the second "King of Medicine" HUMIRA, how to layout patent evergreen and secondary patents?
• Patent review authorization, layout, construction of barriers and risk response for RNAi drugs
• Gene and cell therapy enterprises build effective patent strategies and considerations
• Brand protection enhancement: trademark, brand operation and management practice of pharmaceutical enterprises
|
|
 |
|
Benefits of Attending
• Unique opportunity to raise your profile and showcase your expertise of your organization in Pharma IP area
• Enhancing and establish your partnerships with In-house counsel and industry peers globally to protect your patents and market exclusivity
• Catch up the global pharma IP landscape and trends to build your strategies to adapt it
• Exploring the opportunities of China’s pharmaceutical market and its impact on global innovation system
• Branding your IP services by in-depth conversation,speaking and exhibition booth in front of global pharma IP professionals throughout this three days pharma IP focused summit
• Getting Insights from leading in-house IP counsel, patent prosecutors and litigators, government officials and policy experts from around the world on latest and hottest pharma IP issues facing IP professions today
• Arranging meetings with participants during the conference (Pre-Conference workshops, Tea break, Cocktail parties and Lunches )by using IFPF 2023 online networking system
|
|
